PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,708,005 | +32.6% | 510,555 | 0.0% | 0.38% | +40.1% |
| Q4 2022 | $4,303,979 | -49.4% | 510,555 | 0.0% | 0.27% | -33.7% |
| Q3 2022 | $8,506,000 | +13.2% | 510,555 | 0.0% | 0.41% | +9.7% |
| Q2 2022 | $7,515,000 | -26.1% | 510,555 | +24.5% | 0.37% | -31.1% |
| Q1 2022 | $10,176,000 | +28.4% | 410,155 | +66.0% | 0.54% | +43.2% |
| Q4 2021 | $7,923,000 | -10.9% | 247,047 | 0.0% | 0.38% | -18.5% |
| Q3 2021 | $8,889,000 | +7.7% | 247,047 | +32.1% | 0.46% | +25.7% |
| Q2 2021 | $8,253,000 | -3.5% | 187,047 | 0.0% | 0.37% | +3.7% |
| Q1 2021 | $8,556,000 | -33.7% | 187,047 | 0.0% | 0.35% | -36.2% |
| Q4 2020 | $12,910,000 | – | 187,047 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |